Ayami Yoshimi Selected Research

Ayami Yoshimi Research Topics

Disease

6	Aplastic Anemia (Anemia, Hypoplastic) 05/2016 - 04/2003
4	Juvenile Myelomonocytic Leukemia 04/2015 - 07/2008
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2021 - 03/2014
3	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2016 - 12/2008
3	Cytopenia 03/2016 - 03/2007
2	Leukemia 04/2016 - 04/2003
2	Pathologic Complete Response 09/2014 - 04/2003
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2011 - 07/2005
2	Hematologic Neoplasms (Hematological Malignancy) 12/2011 - 12/2008
1	Macrocytic Anemia 11/2022
1	Brown-Vialetto-Van Laere syndrome 11/2022
1	Sideroblastic Anemia 11/2021
1	chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature 10/2021
1	Acute Disease 01/2021
1	Infections 01/2021
1	Bronchiolitis Obliterans Syndrome 01/2021
1	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 10/2018
1	Bone Marrow Failure Disorders 01/2016
1	Blast Crisis (Blast Phase) 06/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2014
1	Wiskott-Aldrich Syndrome 05/2013
1	Philadelphia Chromosome 02/2010
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2010
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 03/2009
1	Hypersensitivity (Allergy) 07/2008
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 07/2006
1	Bacterial Infections (Bacterial Infection) 07/2006
1	Disease Progression 03/2002
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2002
1	Deglutition Disorders (Dysphagia) 01/2002
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2002

Drug/Important Bio-Agent (IBA)

5	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 04/2014 - 04/2003
2	Azacitidine (5 Azacytidine)FDA Link 03/2016 - 04/2015
2	Methotrexate (Mexate)FDA LinkGeneric 12/2011 - 12/2008
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2009 - 07/2008
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2007 - 04/2003
1	Riboflavin (Vitamin B2)FDA LinkGeneric 11/2022
1	IronIBA 11/2021
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 06/2014
1	thymoglobulin FDA Link 04/2014
1	Proteins (Proteins, Gene)FDA Link 05/2013
1	Imatinib Mesylate (Gleevec)FDA Link 02/2010
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2006
1	Vincristine (Oncovin)FDA LinkGeneric 04/2003
1	HLA-DR Antigens (HLA-DR)IBA 04/2003
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2003
1	Prednisolone (Predate)FDA LinkGeneric 04/2003
1	Asparaginase (Elspar)FDA Link 04/2003
1	Etoposide (VP 16)FDA LinkGeneric 04/2003
1	PerforinIBA 03/2002
1	DNA (Deoxyribonucleic Acid)IBA 03/2002

Therapy/Procedure

7	Therapeutics 11/2022 - 07/2006
7	Hematopoietic Stem Cell Transplantation 11/2021 - 07/2006
5	Transplantation 01/2021 - 09/2008
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2016 - 03/2002
3	Stem Cell Transplantation 10/2018 - 12/2011
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 04/2016
1	Drug Tapering 03/2016
1	Homologous Transplantation 01/2016
1	Combination Drug Therapy (Combination Chemotherapy) 04/2003
1	Adenoidectomy 01/2002
1	General Anesthesia 01/2002